|
Volumn 12, Issue 9, 2005, Pages 1327-1331
|
Neonatal consequences of benzodiazepines used during the last month of pregnancy;Retentissement néonatal de l'exposition aux benzodiazépines en fin de grossesse
|
Author keywords
Adverse effects; Benzodiazepine; Infant; Newborn; Pregnancy
|
Indexed keywords
ALPRAZOLAM;
BENZODIAZEPINE;
BROMAZEPAM;
CLORAZEPATE DIPOTASSIUM;
CLOTIAZEPAM;
OXAZEPAM;
PRAZEPAM;
TEMAZEPAM;
ZOLPIDEM;
AGITATION;
APNEA;
ARTICLE;
DELIVERY;
DRUG INDUCED DISEASE;
HUMAN;
HYPOVENTILATION;
MAJOR CLINICAL STUDY;
MATERNAL TREATMENT;
MUSCLE HYPOTONIA;
NEWBORN;
NEWBORN DISEASE;
PREGNANCY;
PRENATAL EXPOSURE;
SIDE EFFECT;
SOMNOLENCE;
WITHDRAWAL SYNDROME;
ADULT;
BENZODIAZEPINES;
DRUG MONITORING;
FEMALE;
GABA MODULATORS;
HOSPITALIZATION;
HUMANS;
HYPOVENTILATION;
INFANT, NEWBORN;
INFANT, NEWBORN, DISEASES;
MATERNAL-FETAL EXCHANGE;
MUSCLE HYPOTONIA;
NEONATAL ABSTINENCE SYNDROME;
OXAZEPAM;
PREGNANCY;
PREGNANCY OUTCOME;
PREGNANCY TRIMESTER, THIRD;
RECEPTORS, GABA-A;
RESPIRATION;
RISK FACTORS;
|
EID: 23944501484
PISSN: 0929693X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.arcped.2005.03.055 Document Type: Article |
Times cited : (28)
|
References (13)
|